flucloxacillin 250mg powder for solution for injection or infusion
wockhardt uk limited - flucloxacillin sodium, monohydrate - powder for solution for injection/infusion - flucloxacillin sodium monohydrate 250 milligram(s) - antibacterials for systemic use
flucloxacillin vale pharmaceuticals 250 milligram pdr for soln inj/inf
vale pharmaceuticals ltd - flucloxacillin sodium - pdr for soln inj/inf - 250 milligram - beta-lactamase resistant penicillins
flucloxacillin vale pharmaceuticals 500 milligram pdr for soln inj/inf
vale pharmaceuticals ltd - flucloxacillin sodium - pdr for soln inj/inf - 500 milligram - beta-lactamase resistant penicillins
flucloxacillin vale pharmaceuticals 1000 milligram pdr for soln inj/inf
vale pharmaceuticals ltd - flucloxacillin sodium - pdr for soln inj/inf - 1000 milligram - beta-lactamase resistant penicillins
flucloxacillin vale pharmaceuticals 2000 milligram pdr for soln inj/inf
vale pharmaceuticals ltd - flucloxacillin sodium - pdr for soln inj/inf - 2000 milligram - beta-lactamase resistant penicillins
flucloxacillin apotex flucloxacillin (as sodium) 500 mg capsule blister pack
apotex pty ltd - flucloxacillin sodium monohydrate -
flucloxacillin apotex flucloxacillin (as sodium) 250 mg capsule blister pack
apotex pty ltd - flucloxacillin sodium monohydrate -
flucloxacillin (origen)
origen pharmaceuticals limited - flucloxacillin sodium monohydrate 25 mg/ml equivalent to flucloxacillin 25 mg/ml; - powder for oral suspension - 125 mg/5ml - active: flucloxacillin sodium monohydrate 25 mg/ml equivalent to flucloxacillin 25 mg/ml
dicloxacillin sodium capsule
avera mckennan hospital - dicloxacillin sodium (unii: 4hzt2v9kx0) (dicloxacillin - unii:cof19h7wbk) - dicloxacillin 250 mg
dariclox- cloxacillin sodium suspension
merck sharp & dohme corp. - cloxacillin sodium (unii: 65lcb00b4y) (cloxacillin - unii:o6x5qgc2vb) - cloxacillin 200 mg in 10 ml - indications: dariclox is indicated in the treatment of bovine mastitis in lactating cows due to streptococcus agalactiae and nonpenicillinase-producing staphylococcus aureus . clinical experience indicates that antibiotic efficacy in the treatment of mastitis in lactating cows is directly related to the duration of infection. therefore, treatment should be instituted as early as possible after detection.